Demonstrates that peptide-modified molecular tweezers inhibit survivin and histone H3 interaction, suggesting a new approach to target mitotic processes.
Peptide-modified supramolecular tweezers, a promising new class of chemical tools, were designed and employed to inhibit the interaction of the BIR domain of human survivin, a member of the chromosomal passenger complex (CPC), with the phosphorylated histone H3 N-terminal peptide. Fluorescence polarization measurements revealed a nanomolar affinity of the BIR domain for the peptide-tweezer, depending on the presence of lysine residue 121, as proven by the K121A mutant of survivin. Two crystal structures of C-terminally truncated human survivin with the peptide-tweezer molecules demonstrated that the peptide moiety binds the BIR domain as expected from the well-known published crystal structures of survivin with various peptides, but the tweezer itself, surprisingly, was bound to a putative Ca 2+ ion and the side chain of Pro26, corresponding to a previously unknown binding mode. Guided by the accessibility of survivin’s lysine residues in the CPC, a number of new promising peptide tweezers was synthesized, able to connect both binding sites on the protein.
No takes yet. Share an insight, caveat, or question.
Gsell et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: